As of Nov 19, 2026, 1 of 2 active firms rate MOLN a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
MOLN EPS & revenue forecast
EPS · NEXT QUARTER
$-0.37
Range $-0.37 – $-0.37 · 1 analysts
Next period, 1 analysts expect Molecular Partners AG ADR to earn $-0.37 a share (range $-0.37 – $-0.37), versus — a year earlier. Full-year consensus is $-1.37, growing to $-1.06 the year after.
REVENUE · NEXT QUARTER
$0
Range $0 – $0 · 1 analysts
Revenue is expected to reach $0 (range $0 – $0). Full-year consensus is $0, rising to $0 next year.
Top analysts covering Molecular Partners AG ADR
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on MOLN.
#1
RB
Robert Burns
HC Wainwright & Co. · Rank #215
Buy
$13.00+387.8% to target
Overall win rate
42%
+ Follow
#2
RV
Richard Vosser
JP Morgan
Neutral
$3.75+40.7% to target
Coverage
—
+ Follow
#3
Jonathan Chang
Leerink Partners
Buy
No targeton MOLN
Coverage
—
+ Follow
#4
WM
William Maughan
Clear Street
Buy
$8.00+200.2% to target
Coverage
—
+ Follow
MOLN stock forecast FAQ
What is MOLN's average 12-month price target?+
The 2 active firms with a live target average $8.38 for Molecular Partners AG ADR over the next 12 months, ranging from a $13.00 high to a $3.75 low, as of Nov 19, 2026.
Is MOLN stock a Buy, Sell or Neutral right now?+
The current consensus is Insufficient coverage. Of the 2 active firms as of Nov 19, 2026, 1 rate it Buy or Strong Buy, 1 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for MOLN?+
The Street-high target is $13.00 (HC Wainwright & Co.), and the Street-low is $3.75 (JP Morgan). The average of all 2 active-firm targets is $8.38.
How many active Wall Street firms cover MOLN?+
2 active firms have a recognized rating on Molecular Partners AG ADR as of Nov 19, 2026, and 2 active firms carry a live 12-month price target.
Who is the most accurate analyst covering MOLN?+
Among analysts who currently cover MOLN, Robert Burns of HC Wainwright & Co. has the strongest overall Quantellect track record (Rank #215). Their current call is Buy with a $13.00 target.
What is Molecular Partners AG ADR's projected EPS for next quarter?+
The consensus estimate is $-0.37 per share (range $-0.37 – $-0.37) across 1 analysts. Full-year EPS is projected at $-1.37, rising to $-1.06 the following year.
How much revenue is Molecular Partners AG ADR expected to report next quarter?+
Consensus revenue is $0 (range $0 – $0). Full-year revenue is projected at $0, growing to $0 next year.
Have analysts been upgrading or downgrading MOLN lately?+
As of Nov 19, 2026, 1 of 2 active firms rate MOLN a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their MOLN calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.